69 related articles for article (PubMed ID: 3011483)
1. Effect of a monoclonal antibody against GPs IIb-IIIa on platelet aggregation and ATP secretion.
Balduini CL; Sinigallia F; Damiani G; Bertolino G; Bisio A; Zocchi E
Exp Hematol; 1986 Jun; 14(5):338-42. PubMed ID: 3011483
[TBL] [Abstract][Full Text] [Related]
2. [Production and application of anti-human platelet GP IIb/IIIa monoclonal antibodies].
Wu XW
Zhonghua Yi Xue Za Zhi; 1989 Aug; 69(8):427-30, 30. PubMed ID: 2620270
[TBL] [Abstract][Full Text] [Related]
3. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M
J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146
[TBL] [Abstract][Full Text] [Related]
4. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
5. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
[TBL] [Abstract][Full Text] [Related]
6. Effect of acetylsalicylic acid on inhibition of ex vivo platelet aggregation and secretion by SKF 107260, a novel GPIIb/IIIa receptor antagonist.
Freed MI; Boike S; Zariffa N; Jorkasky DK
Thromb Haemost; 1994 Oct; 72(4):622-6. PubMed ID: 7878642
[TBL] [Abstract][Full Text] [Related]
7. Effects of ethanol on pathways of platelet aggregation in vitro.
Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
[TBL] [Abstract][Full Text] [Related]
8. Trimucytin: a collagen-like aggregating inducer isolated from Trimeresurus mucrosquamatus snake venom.
Teng CM; Ko FN; Tsai IH; Hung ML; Huang TF
Thromb Haemost; 1993 Mar; 69(3):286-92. PubMed ID: 8470053
[TBL] [Abstract][Full Text] [Related]
9. [Effect of heparin on platelet aggregation in vitro].
Róka L; Isert D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
[TBL] [Abstract][Full Text] [Related]
10. An antiplatelet monoclonal antibody that inhibits ADP and epinephrine-induced aggregation.
Vilella R; Lozano T; Mila J; Borche L; Ercilla G; Ordinas T; Vives J
Thromb Haemost; 1984 Feb; 51(1):93-6. PubMed ID: 6232732
[TBL] [Abstract][Full Text] [Related]
11. Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex.
Di Minno G; Thiagarajan P; Perussia B; Martinez J; Shapiro S; Trinchieri G; Murphy S
Blood; 1983 Jan; 61(1):140-8. PubMed ID: 6216929
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies against platelet membrane glycoproteins IIb/IIIa and Ibalpha inhibit platelet dependent thrombin generation by different mechanisms.
Thomas S; Metcalfe P; Goodall AH; Gray E
Thromb Haemost; 2000 Jul; 84(1):98-103. PubMed ID: 10928478
[TBL] [Abstract][Full Text] [Related]
13. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
[TBL] [Abstract][Full Text] [Related]
15. Interaction of wheat germ agglutinin and concanavalin A with platelets. Stimulation of platelet functional reactions and binding with membrane glycoproteins.
Smirnova IV; Khaspekova SG; Ignatov VV; Mazurov AV
Biochemistry (Mosc); 1998 Jun; 63(6):710-8. PubMed ID: 9668212
[TBL] [Abstract][Full Text] [Related]
16. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
17. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing the deaggregation of human and rabbit platelets.
Kinlough-Rathbone RL; Mustard JF; Perry DW; Dejana E; Cazenave JP; Packham MA; Harfenist EJ
Thromb Haemost; 1983 Jun; 49(3):162-7. PubMed ID: 6308846
[TBL] [Abstract][Full Text] [Related]
19. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R
Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of platelet aggregation with monoclonal antibodies to the glycoprotein IIb-IIIa complex].
Byzova TV; Vlasik TN; Mazurov AV
Biull Eksp Biol Med; 1994 Oct; 118(10):402-5. PubMed ID: 7865820
[No Abstract] [Full Text] [Related]
[Next] [New Search]
